Investor
The company plans to use the new money to grow out its business and sales team.
The company plans to use this M&A to gain a foothold in the Medicare space.
Also: Phil scores $100 million for its prescription refill platform and Synchron rakes in $40 million.
The health startup provides telemedicine services for insurance companies, corporations and government entities.
The deal is expected to close in the second half of 2021 and be worth roughly $4.2 billion.
With this raise, in addition to Nayya’s Series A round from earlier this year, the company has raised nearly $50 million to date.
Frost & Sullivan says the recent shift in attention away from primarily focusing on reproductive-age issues to untapped market areas will be a key factor to the sector’s growth.
From unlocking new patient data to looking beyond the apps for digital care, how the digital infrastructure needs to change for the future.
The Canadian Trade Commission's accelerator angles to help young companies get their start in the U.S. and other nations.
The company plans to use the new funds to expand its therapeutics beyond ADHD.